/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Longeveron Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$0.63 -0.0116(-1.16%) LGVN at 04 Dec 2025 04:36 PM Biotechnology
Lowest Today 0.63495
Highest Today 0.6549
Today’s Open 0.65
Prev. Close 0.644
52 Week High 2.24
52 Week Low 0.59
Day’s Range: Low 0.63495 High 0.6549
52-Week Range: Low 0.59 High 2.24
1 day return -
1 Week return -2.48
1 month return -16.49
3 month return -14.6
6 month return -47.06
1 year return -67.97
3 year return -98.25
5 year return -
10 year return -

Institutional Holdings

Vanguard Group Inc 0.69

Geode Capital Management, LLC 0.68

Vanguard Institutional Extnd Mkt Idx Tr 0.48

Citadel Advisors Llc 0.45

UBS Group AG 0.40

Fidelity Extended Market Index 0.35

XTX Topco Ltd 0.23

State Street Corp 0.22

Capital Investment Advisory Services, LLC 0.13

Commonwealth Equity Services Inc 0.12

Fidelity Total Market Index 0.12

Fidelity Series Total Market Index 0.10

Northern Trust Corp 0.08

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Spartan Extended Market Index Pool F 0.07

Lido Advisors, LLC 0.05

BlackRock Inc 0.05

Bank of Montreal 0.05

BMO Capital Markets Corp. 0.05

Spartan Total Market Index Pool G 0.03

Tower Research Capital LLC 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

NT Ext Eq Mkt Indx Fd DC Lend T3 0.02

Fidelity Nasdaq Composite Index 0.01

Steward Partners Investment Advisory, LLC 0.01

Advisor Group Holdings, Inc. 0.01

Extended Equity Market Fund K 0.01

Morgan Stanley - Brokerage Accounts 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Extended Equity Market Fund M 0.00

Bank of America Corp 0.00

Hanson Mcclain Inc 0.00

State St US Extended Mkt Indx NL Cl C 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Northern Trust Wilshire 5000 0.00

SBI Securities Co Ltd 0.00

SSgA U.S. Total Market Index Strategy 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Market Status

Strong Buy: 0

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 14.72 M

PB Ratio 1.3638

PE Ratio 0.0

Enterprise Value 5.33 M

Total Assets 25.56 M

Volume 456478

Company Financials

Annual Revenue FY23:767000 0.8M, FY22:1222000 1.2M, FY21:1306000 1.3M, FY20:5629531 5.6M, FY19:5639466 5.6M

Annual Profit FY23:168000 0.2M, FY22:497000 0.5M, FY21:590000 0.6M, FY20:1826270 1.8M, FY19:1754076 1.8M

Annual Net worth FY23:-19842000 -19.8M, FY22:-19627000 -19.6M, FY21:-17164000 -17.2M, FY20:-3791220 -3.8M, FY19:-2995507 -3.0M

Quarterly Revenue Q3/2025:137000 0.1M, Q2/2025:316000 0.3M, Q1/2025:381000 0.4M, Q3/2024:773000 0.8M, Q2/2024:468000 0.5M

Quarterly Profit Q3/2025:125000 0.1M, Q2/2025:146000 0.1M, Q1/2025:275000 0.3M, Q3/2024:682000 0.7M, Q2/2024:344000 0.3M

Quarterly Net worth Q3/2025:-7221000 -7.2M, Q2/2025:-5028000 -5.0M, Q1/2025:-5011000 -5.0M, Q3/2024:-4419000 -4.4M, Q2/2024:-3413000 -3.4M

Fund house & investment objective

Company Information Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO Mr. Than Powell

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow